Navigation Links
Isis Announces HSR Approval and Closure of Its Collaboration With Ortho-McNeil, Inc.
Date:10/2/2007

CARLSBAD, Calif., Oct. 2 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) today announced that it has received clearance under the Hart-Scott-Rodino Antitrust Improvements Act for its collaboration with Ortho-McNeil, Inc., a Johnson & Johnson company, which was announced on September 13, 2007.

As part of the collaboration, Isis is granting to Ortho-McNeil worldwide development and commercialization rights to two of its diabetes drugs, ISIS 325568 and ISIS 377131, which selectively inhibit the production of glucagon receptor (GCGR) and glucocorticoid receptor (GCCR), respectively. Additionally, Ortho-McNeil will provide funding to Isis to support the joint discovery of novel drugs to treat metabolic diseases, including diabetes and obesity.

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. The Company has successfully commercialized the world's first antisense drug and has 17 drugs in development. Isis' drug development programs are focused on treating cardiovascular and metabolic diseases. Isis' partners are developing drugs for a wide variety of diseases. Ibis Biosciences, Inc., Isis' wholly owned subsidiary, is developing and commercializing the Ibis T5000(TM) Biosensor System, a revolutionary system to identify infectious organisms. As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,500 issued patents worldwide. Additional information about Isis is available at http://www.isispharm.com.

This press release includes forward-looking statements regarding Isis' c
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...type device to be coupled with Stem Cell Therapy. ...ovember 24, 2009 -- Entest Biomedical, Inc. (OTC...ons with a manufacturer of lasers regarding the de...l be owned by Entest and used in conjunction with ...ped by Entest. These therapies are aimed at increa...
(Date:11/24/2009)...l Tips to Get a Leg Up From the American Podiatric...thesda, Md. (Vocus) November 24, 2009 -- The avera...dash;but that number dramatically increases during...s alike continue making their holiday travel plans...ar the brunt of aches and pains while on the road....
(Date:11/24/2009)...wire/--MinuteClinic,thepioneerandlargestproviderof...tsfirstretailhealthcarecenterinWashington,D.C.insi...pensevendaysaweekandwillservepatientsinNortheastne...anPark,AtlasDistrict,IvyCityandtheGallaudetUnivers...ore-basedclinic,weareexpandingaccesstohigh-quality...
(Date:11/24/2009)...wswire-FirstCall/--AflacIncorporated(NYSE: AFL )an...dtheexchangeoftwoofitsinvestmentsecuritiesownedbyA...November3,2009,andtheexchangesareexpectedtosettleo...flacwillhaveexchangeditsinvestmentinLloydsTSBBankp...arvalueof$222millionatSeptember30,2009)intoyen-den...
(Date:11/24/2009)...redators, but few fear cyberbullying, survey finds...- More than four in five parents say their childre...at the same time almost two-thirds are worried abo...The findings, released online Nov. 19 by the C.S. ...,s Health, show that parents have a variety of con...
Breaking Medicine News(10 mins):Health News:Entest Biomedical Enters into Discussions with Laser Manufacturer to Develop Proprietary Photoceutical Device for COPD Treatment 2Health News:Keep Holiday Travel Foot-Friendly 2Health News:Keep Holiday Travel Foot-Friendly 3Health News:MinuteClinic Opens First Retail Clinic in Washington, D.C. at CVS/pharmacy Store in Northeast 2Health News:MinuteClinic Opens First Retail Clinic in Washington, D.C. at CVS/pharmacy Store in Northeast 3Health News:Aflac To Exchange Two Lloyds Banking Group Securities, Enhance Risk-Based Capital Ratio 2Health News:Aflac To Exchange Two Lloyds Banking Group Securities, Enhance Risk-Based Capital Ratio 3Health News:Aflac To Exchange Two Lloyds Banking Group Securities, Enhance Risk-Based Capital Ratio 4Health News:Parents Worry About Their Kids' Safety on the Internet 2
... gets tough, the tough get fitter, and healthier. ...is still going strong despite these challenging ec...owth strategy not only for this year but for many ...ak. , , Known for its innovative results-oriente...
...ry in Miami today convicted two physicians and two...ion Medicare fraud scheme, Acting Assistant Attorn... and U.S. Attorney R. Alexander Acosta of the Sout...65; Eda Marietta Milanes, 43; and Jorge Luis Pache...
...amp; Sullivan will present the 2009 Excellence in... Market to Epinex for developing the G1A(TM) Rapi...livan is an internationally renowned market resear...llence in Medical Technologies & Life Sciences...
...ng event was announced today by the American Red C...ter Los Angeles Red Cross is hosting a lunch recep...ency Operations Center (EOC), which is ready to be...ge will run throughout the event. , , Who: More...
...ty revenue triples and GCC sales start , , QUEBEC...e Inc. (TSX: CUR), a life sciences company commerc...livering lab services, announced a net loss of $3,...eflect budgeted sales and marketing initiatives to...
...argest water efficiency conference Oct. 7-9 in Las...t of its ongoing commitment to encourage efficient... Association (AWWA), the authoritative resource o...ed last year by the Southern Nevada Water Authorit...
Other Medicine News:Health News:Equinox Fitness Clubs Grows With The Flow 2Health News:Jury Convicts Two Doctors and Two Medical Assistants in $5.3 Million Medicare Fraud Scam 2Health News:Jury Convicts Two Doctors and Two Medical Assistants in $5.3 Million Medicare Fraud Scam 3Health News:Jury Convicts Two Doctors and Two Medical Assistants in $5.3 Million Medicare Fraud Scam 4Health News:Frost and Sullivan Picks Epinex for Diabetes Research Award 2Health News:State-of-the-Art Preparedness: L.A. Red Cross Opens Advanced Emergency Operations Center 2Health News:DiagnoCure announces first quarter 2009 results 2Health News:DiagnoCure announces first quarter 2009 results 3Health News:DiagnoCure announces first quarter 2009 results 4Health News:DiagnoCure announces first quarter 2009 results 5Health News:DiagnoCure announces first quarter 2009 results 6Health News:AWWA partners with WaterSmart Innovations conference 2
(Date:11/24/2009)...RNewswire-FirstCall/--ZimmerHoldings,Inc.(NYSE: ZM...e21stAnnualPiperJaffrayHealthCareConferenceinNewYo... ,, Alivewebcastofthepresentationcanbeaccessedv...or.zimmer.com .Thewebcastwillbearchivedforreplayfo..., Foundedin1927andheadquarteredinWarsaw,Indiana,Zi...
(Date:11/24/2009)...wswire-FirstCall/--OptimerPharmaceuticals,Inc.(Nas...rJaffrayHealthCareConferenceatTheNewYorkPalaceinNe..., (Logo: http://www.newscom.com/cgi-bin/prnh/200...resentationwillbeaccessibleontheInvestorspageofthe...softhispresentationwillbeavailableatthesamelocatio...
(Date:11/23/2009)...Newswire-FirstCall/--HealthWarehouse.com,Inc.(OTCB...odayannounceditsfinancialresultsforthethirdquarter...evenueof$1,006,721,drivenbyheavygrowthinprescripti...3.0%year-over-yearto34.6%andthenetlossforthequarte...emonthsendedSeptember30,2008. ,, "Wecontinuetos...
Breaking Medicine Technology:HealthWarehouse.com, Inc. Announces Third Quarter Financial Results; Revenues, Margins, and Orders Shipped Increase Over Third Quarter 2008 2HealthWarehouse.com, Inc. Announces Third Quarter Financial Results; Revenues, Margins, and Orders Shipped Increase Over Third Quarter 2008 3Study Counters Warnings on Quit Smoking Drug 58757 1Study Counters Warnings on Quit Smoking Drug 58757 2Health Enhancement Products Reacquires ProAlgaZyme 28TM 29 Distribution and Marketing Rights 58753 1Health Enhancement Products Reacquires ProAlgaZyme 28TM 29 Distribution and Marketing Rights 58753 2American Lung Association of Florida South Area Encourages Miami Residents to See Themselves Among the Many Faces of Influenza 58749 1American Lung Association of Florida South Area Encourages Miami Residents to See Themselves Among the Many Faces of Influenza 58749 2American Lung Association of Florida South Area Encourages Miami Residents to See Themselves Among the Many Faces of Influenza 58749 3American Lung Association of Florida South Area Encourages Miami Residents to See Themselves Among the Many Faces of Influenza 58749 4American Lung Association of Florida South Area Encourages Miami Residents to See Themselves Among the Many Faces of Influenza 58749 5
...ecordAF Registry Baseline Data and New Data from t... Study, PARIS, Nov. 4 , Live Webcast Media Br... 2008 - 14.00-15.00am CET, Background:, -- AF is... increased morbidity and mortality, -- There ...ecordAF, which takes a closer look at disease ...
...PA, Fla., Nov. 3 Sirion Therapeutics, Inc., a,pri...ompany, announced,today that studies of two invest...tentially blinding eye diseases will be presented ...n Uveitis Society,s annual,invitational meeting (N...iminary results will be presented from an anterior...
Other Medicine Technology:Tackling Atrial Fibrillation and Associated Cardiovascular Risk 2Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Treatments for Leading Causes of Blindness to Be Presented 2Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Treatments for Leading Causes of Blindness to Be Presented 3Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Treatments for Leading Causes of Blindness to Be Presented 4Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Treatments for Leading Causes of Blindness to Be Presented 5
Schepens Depressor 8.0mm Wide Tip Thimble Size 12
Yavitz Flap Cover
Chayett Drainage Ring
Weck-Cel Points
Medicine Products: